Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials
JAMA Intern Med 2022 Mar 28;[EPub Ahead of Print], L He, J Wang, F Ping, N Yang, J Huang, Y Li, L Xu, W Li, H ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.